Pfizer targets fat dogs

The Food and Drug Administration said Friday it approved a Pfizer drug designed to help cut the weight off fat dogs.

Pfizer will market Slentrol, a liquid formula, to owners of the estimated 5 percent of U.S. dogs that are 20 percent above their ideal weight.

This should make shareholders happy.

After all, based on the torcetrapib fiasco, Pfizer's hasn't done too well treating people lately .